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The Effects of SNAP-25 Deficits and Pre-Natal Nicotine in a Mouse and 
ADHD Model 
Adcock J., Haney M., Leonard D., Allan A. 
University of New Mexico, Albuquerque 
 
 
It has been recognized that the foundation of most, if not all, complex disease processes, 
particularly neuropsychiatric disorders, is due to the interactions between subtle genetic 
deficits and environmental insults.  One of the most studied neuropsychiatric disorders 
shown to contribute from both heritable-related factors and environmental stressor 
sensitivity is Attention Deficit Hyperactivity Disorder (ADHD). Of the heritable issues 
involved, meta-analysis of genetic linkage studies has shown that the SNARE protein 
SNAP-25, is one of many possible proteins that may provide answers to the genetic 
component. In contrast to this genetic factor, studies have shown that prenatal nicotine 
exposure causes a direct effect to the fetus and predisposes them to nicotine and 
substance abuse behavior. Finally, preliminary studies have shown that heterozygote 
SNAP-25 deficient mice following in-utero exposure to nicotine are, in fact, hyperactive 
compared to their wild type littermates. To study the relationship between SNAP-25 and 
prenatal nicotine exposure with locomotor activity, we compared wild type mice with and 
without nicotine exposure to SNAP-25 wild type mice with and without nicotine 
exposure. Additionally, this study also examined prenatal nicotine exposed SNAP-25 
heterozygous mice with their wild type counterpart with intraperitoneal cocaine to see if 
the combination of factors increased the likelihood of substance abuse potential. The 
results demonstrated that prenatal nicotine exposed mice had greater locomoter activity 
and substance abuse behavior. Moreover the SNAP-25 heterozygous genotype 
compounded both of these affects and demonstrated greater results. 
 
INTRODUCTION 
 
It has been recognized that the foundation 
of most, if not all, complex disease 
processes, particularly neuropsychiatric 
disorders, is due to the interactions 
between subtle genetic deficits and 
environmental insults.  ADHD is defined 
as a child exhibiting behaviors such as 
hyperactivity, inattentiveness, and 
compulsive-like attitude.  ADHD is a 
common childhood disorder that has been 
shown to be influenced by both genetic 
and environmental factors, the latter of 
which is a current research interest.  Many 
studies have shown an association exists 
between prenatal tobacco smoke exposure 
and the eventual diagnosis of ADHD.  Of 
note, it is estimated that 11% of U.S. 
pregnant women smoke during their 
pregnancy (11).  Furthermore, many 
clinical and epidemiological studies have 
shown that children exposed to nicotine in 
utero are at increased risk of developing 
ADHD, major depressive disorder 
(MDD), substance abuse, conduct 
disorder, and antisocial behavior 
(4,10,12,13,16). This has thought to result 
from nicotine interacting with neuronal 
nicotinic receptors consequently 
stimulating them and turning on genes 
that control cell replication, 
differentiation, growth, and death of 
involved limibic and frontal cortex cells. 
Of the genetic factors, SNAP-25 is a 
synaptosomal-associated protein of 
25kDa, located on chromosome 20p12, 
that is involved in the release of 
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presynaptic neurotransmitters.  It encodes 
for a presynaptic membrane protein that is 
part of the SNARE complex (along with 
synaptobrevin and syntaxin) which is 
essential for synaptic neuroexocytosis. 
Several single nucleotide polymorphisms 
(SNPs) in this gene have been implicated 
to have an association with ADHD (8).  
Interestingly, Coloboma mice (which is a 
proposed animal model for ADHD 
because of their locomotive 
hyperactivity), are hemizygously lacking 
the chromosomal area for SNAP-25.  
Their locomotor hyperactivity decreases 
when provided either transgenic SNAP-25 
or amphetamines (7,17). 
Whether these syndromes are caused by 
nicotine exposure, genetic and/or 
psychosocial adversities associated with 
maternal smoking is not completely clear. 
Animal models suggest a direct impact of 
PNE. However, the fact that nicotine is 
forcefully administrated in these 
paradigms raises some questions about the 
specificity of these findings. The goal of 
this study is to further investigate the 
association of genetic and environmental 
factors on ADHD by looking at the 
genetic susceptibility of heterozygote 
SNAP-25 mice and the addictive behavior 
associated with an often-used drug, 
cocaine. 
 
METHODS 
 
Animals 
All behavior tests were conducted on 
experimentally naive adult (60-100 days 
of age offspring of C57BI/6J dams 
prenatally exposed to saccharin (.066%) 
sweetened nicotine (0.05 mg/ml) or 
saccharine (.066%) only solutions (as 
shown in Figure 1). Additionally, mice 
were provided standard laboratory mouse 
chow along with fresh water at their will. 
Offspring were housed in a temperature-
controlled vivarium with a 12 hr 
light/dark cycle. All animal procedures 
were approved by the Institutional Animal 
Care and Use Committee.  
 
Locomotor activity measurement 
 
Apparatus: Locomotor activity was 
tested using an automated system (San 
Diego Instruments, San Diego, CA) 
following the method described by Hess 
et al. 1996. Locomotion was defined as 
actual beam interruptions recorded during 
a 10 minute interval with a testing period 
of 180 minutes.  Data from each of the 10 
minute intervals was obtained and the sum 
from the 18 intervals comprised the 
accumulated locomotion score.   
 
Conditioned place preference 
 
Apparatus: Conditioned place preference 
boxes were constructed of Plexiglas with 
2 distinctly different chambers (one black, 
one white) connected by an anteroom with 
a removable door. Assignment of cocaine 
paired side was alternated, such that an 
equal number of mice were assigned the 
white side for cocaine as were assigned to 
the black side for cocaine.  
 
Training: Each mouse received either an 
i.p. dose of cocaine (4 mg/ kg, or saline) 
and confined to either the white or the 
black side of the box for 15 minutes.  
Mice were returned to their home cage for 
4 hours and then given a second injection 
of either drug or saline which ever they 
did not receive in the first injection event, 
and then placed in the alternate chamber.  
Again, the mouse remained confined in 
the alternate side of the box for a 15 
minute increment.  Pairing of chamber 
side (black or white) with injection 
condition (cocaine or saline) was 
counterbalanced across groups (PNE and 
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control) and alternated for time of day (am 
or pm) of which is outlined in Figure 2. 
This process of morning and afternoon 
injections was repeated for 3 consecutive 
days.   Finally, on day 4 mice were placed 
in the anteroom with the door 
subsequently removed and thus giving 
them access to either side of the box. The 
time spent in each chamber was recorded 
for 10 minutes total with the mice having 
free access to either chamber via the 
anteroom.  A total of 3-6 mice per group 
were tested for cocaine conditioned place 
preference.  All conditioning and testing 
was done between 0900-1530 hr under 
dim illumination in a sound attenuated 
room. 
 
 
 
Figure 1 
Nicotine exposure paradigm 
 
 
 
 
 
 
 
 
 
 
• Voluntary drinking paradigm, 2-bottle choice 
• Nicotine 0.05 mg/ml in a 0.066% saccharin solution 
• Average daily nicotine consumption 3.5 mg/kg/day,  
roughly equivalent to 10 cigarettes per day in a 60 kg human. 
 
Figure 2 
Experimental Design for cocaine placed preference 
 
 
 
Mice were injected with either 4 mg/kg cocaine or saline and confined to the side of the 
box for 15 minutes twice a day for 3 consecutive days.  On Day 4, mice are offered 
access to both sides of the box for 10 minutes and the time spent on the black and the 
white side are recorded. 
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RESULTS 
 
Figure 3 
Locomotor Activity Measurement 
 
 
 
The effect of prenatal treatment on spontaneous locomotion in male and female adult 
offspring.  Wild type offspring (blue bars) were those from saccharin drinking mothers 
(light blue) and prenatal nicotine exposed (dark blue mice are presented in the solid bars. 
SNAP-25 HET mice are presented in the turquoise bars with the offspring from saccharin 
drinking mothers in the vertical striped bar and nicotine exposed offspring in the hatched 
bar.  The data are from n = 4-6 mice per group and are mean (+/-SEM) cumulative 
locomotion in a 180 minute continuous test period. 
 
 
Figure 4 
Conditioned Placed Preference 
 
 
 
Cocaine place preference in Wild type PNE mice (light blue bars) or SNAP-25 HET PNE 
mice (dark blue bars).  Cocaine preference is given as time spent on the drug paired side 
divided by the time spent on the saline paired side of the box.  Thus, scores of 1 indicate 
no preference while scores greater than one express preference for the drug. The data are 
from n = 3-6 mice per group. 
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DISCUSSION 
 
In order to evaluate our hypothesis that 
diminished expression of Snap25, 
encoded from a single functional allele, 
may serve as a susceptibility locus acted 
upon by environmental factors, we 
performed an initial limited study 
exposing pregnant Snap25 heterozygous 
dams to consume nicotine through a 
two-bottle choice paradigm and assayed 
the locomotor activity and cocaine 
conditioned place preference of their 
progeny after reaching adulthood  As 
expected, prenatal nicotine exposure led 
to increased activity compared to 
saccharine treated mice in wild type 
mice.  Importantly, this increase was 
significantly exacerbated in HET mice 
(p<0.01), demonstrating that offspring of 
heterozygote dams that have consumed 
nicotine are more hyperactive. Further 
testing demonstrated that HET mice 
prenatally exposed to nicotine were also 
more susceptible to cocaine preference 
as seen in the CPP studies. These 
findings suggest that SNAP-25 mice 
may pose a genetic risk for 
environmental triggers, like nicotine, to 
induce behaviors similar to those seen in 
ADHD.  Additional studies are needed 
to see if the increased hyperactivity and 
drug preference is accompanied by other 
behavioral deficits.  These studies are 
needed to further validate this model of 
gene X environment interaction in 
ADHD. Since it’s been discussed in 
previous studies that nicotine potentially 
plays a role in psychological disorders, 
especially in the prenatal period, it was 
our objective to determine whether a 
SNAP-25 allele deletion would act 
synergistically with PNE to increase the 
likelihood of addictive behavior. Our 
study shows that the mice who contained 
the SNAP-25 deletion, in addition to 
PNE, exhibited a greater degree of 
addictive behavior.  This supports the 
idea that having a known environmental 
risk factor for developing ADHD (PNE) 
along with having a genetic risk factor 
(SNAP-25 HET), affects the severity of 
addictive behavior. This information was 
supported in the observation that the 
mice subjected to cocaine placed i.p. 
injections preferred to reside longer in 
the environment during the time of 
preference selection of which they were 
previously exposed to during their 
dosing periods.  
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